BONUS CAP ZERTIFIKAT - GILEAD SCIENCES Stock

Certificat

DE000VM8MJY7

Real-time Boerse Frankfurt Warrants 10:43:47 2024-07-04 am EDT
74.03 EUR -1.10% Intraday chart for BONUS CAP ZERTIFIKAT - GILEAD SCIENCES
Current month-6.61%
1 month+16.17%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-04 74.03 -1.10%
24-07-03 74.85 -4.42%
24-07-02 78.31 -3.23%
24-07-01 80.92 +0.96%
24-06-28 80.15 -0.16%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 10:43 am EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying GILEAD SCIENCES, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM8MJY
ISINDE000VM8MJY7
Date issued 2024-01-17
Strike 115 $
Maturity 2025-03-21 (260 Days)
Parity 1 : 1
Emission price 93.91
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 92.6
Lowest since issue 61.36
Spread 0.64
Spread %0.86%

Company Profile

Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (98.9%): for the treatment of HIV (63% of net sales), COVID-19 (20.4%), hepatitis C virus (6.6%), hepatitis B virus (3.6%) and other (6.4%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV); - other (1.1%): especially royalties and revenue from research and development services and from subcontracted production of therapeutic products. Net sales are distributed geographically as follows: the United States (69.2%), Europe (16.4%) and other (14.4%).
Sector
-
More about the company

Ratings for Gilead Sciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Gilead Sciences, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
66.59 USD
Average target price
82.97 USD
Spread / Average Target
+24.59%
Consensus